Hold AXP with $290.55 stop; Q3 earnings is binary catalyst; reject all trim proposals per 9/21 binding reflection
Hold AXP with 100% position retained and zero trim executed. The 9/21 reflection is dispositive: two consecutive Underweight calls on this exact setup (9/18 at 50% trim: -0.9% alpha; 9/21 at 25-30% trim: -2.7% alpha) demonstrate that trimming a Berkshire-anchored, buyback-active, 34.4% ROE compounder on technical alignment alone produces negative alpha. Q2 2026 was a record quarter (revenue $19.6B, EPS $4.53, NII growth 11%) with charge-offs not materially deteriorated, and the fundamental bar for trimming has not been crossed. The $290.55 close-on-volume stop defines structural invalidation; Q3 2026 earnings is the binary validation event where charge-off rate trend, cardmember spending growth, and funding cost commentary will determine whether the bear case has been confirmed. If Q3 validates the bear case, proceeds rotate into less-loved quality compounders with cleaner technical structures and lower credit-cycle exposure.
| Position | Action |
|---|---|
| Current position | Maintain 100% position; zero trim per 9/21 binding reflection |
| Q3 net charge-off rate increase >30bps QoQ | Underweight with active trim |
| Q3 cardmember spending growth deceleration below 9% TTM | Underweight with active trim |
| Q3 funding cost commentary signals NIM compression accelerating beyond Q2 trajectory | Underweight with active trim |
| Daily close below $290.55 on volume ≥4M shares | Immediate downgrade to Sell on residual position |
| Berkshire trims AXP in 13F | Underweight with active trim |
AXP at $301.96 is a once-in-a-year entry point into one of the highest-quality financial franchises on Earth, with the technical oversold reading creating a gift rather than a problem.
| Indicator | Value | Signal |
|---|---|---|
| close_10_ema | 315.61 | bearish |
| close_50_sma | 335.10 | bearish |
| close_200_sma | 333.83 | bearish |
| rsi | 27.21 | bullish |
| macd | -7.23 | bearish |
| macd_signal | -5.42 | bearish |
| macd_histogram | -1.80 | bearish |
| bollinger_middle | 323.80 | neutral |
| bollinger_upper | 342.56 | bearish |
| bollinger_lower | 305.04 | bearish |
| atr_14 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Higher Fed rates are a tailwind, not a headwind, for AXP's credit lending model
EV: +46% · concedes: The bear is fighting Berkshire's actual money; Visa's ROE is in the 50s (but Visa doesn't take credit risk); AXP does bear credit risk that pure networks don't carry
AXP's quality franchise does not justify the current price in a hawkish macro regime with accelerating bearish technicals, compressing NII margins, and an imminent death cross — the risk-reward favors selling into rallies rather than buying the dip.
EV: $260 base-case fair value (13x on $20 EPS), $220 conservative (11x), $300 bull case (15x) · concedes: AXP is a quality franchise with 34% ROE, elite customer base, and durable cash flow; 34% ROE, accelerating buybacks, and 17% dividend growth over three years are real; Berkshire anchor is a real signal for quality — though not a timing mechanism; The capital return story is real, though secondary to the earnings story
→ vs conservative: Conservative analyst's trim-and-retain approach is too generous; wanting to keep more position will transform a 16.5% loss into a 40% loss as the credit cycle damage materializes 12-18 months post-tightening.
→ vs neutral: HOLD thesis is backward-looking — Platinum refresh Q2 2026 record quarter is priced in; Berkshire's retention of AXP is a long-term inheritance signal, not a trade signal; RSI at 27 without bullish divergence is not a 'coiled spring' but market in freefall.
| 6.56 |
| neutral |
| latest_close | 301.96 | bearish |
| day_high | 305.67 | neutral |
| day_low | 301.29 | bearish |
| volume | 3520239 | bearish |
Support: 301.96 · 298 · 295 · 290.55 | Resistance: 305.04 · 315.61 · 323.8 · 333.83 · 335.1 · 342.56
AXP is in a well-established downtrend with price at 301.96 having declined roughly 16.5% from the July 2026 swing high of 361.57. The stock closed below its lower Bollinger Band (305.04) on 3.52M volume — a statistically rare ~2 standard deviation event. Technical indicators show extreme oversold conditions: RSI at 27.21 (below the 30 threshold), MACD histogram expanding bearish at -1.80, and all moving averages stacked bearish (price is 10% below the 50 SMA at 335.10 and 9.5% below the 200 SMA at 333.83). ATR is elevated at 6.56, indicating high realized volatility requiring wide stops of 10–13 points. Key support lies at 301.96 and the March swing low of 290.55, while resistance clusters at 323.80 (Bollinger middle), 335.10 (50 SMA), and 342.56 (Bollinger upper). No bullish divergence is visible yet, and the highest-probability near-term scenario is either continued consolidation with higher lows above ~302 or a bounce toward 305.04 (lower band reversion) followed by resistance rejection.
Market Cap
$203.9 B
P/E (TTM)
18.33
Forward P/E
14.98
PEG Ratio
1.24
Price / Book
5.95
EPS (TTM)
$16.47
Forward EPS
$20.16
Dividend Yield
1.25%
Beta
1.05
52-Week High
$387.49
52-Week Low
$290.97
50-Day Avg
$335.16
200-Day Avg
$335.02
Book Value / Share
$50.79
Revenue (TTM)
$70.91 B
Gross Profit
$44.21 B
Net Income
$11.31 B
Profit Margin
16.14%
Operating Margin
20.32%
Return on Equity (ROE)
34.38%
Return on Assets (ROA)
3.79%
Total Revenue (FY 2025)
$72,230 M
Total Revenue (FY 2024)
$65,949 M
Total Revenue (FY 2023)
$60,515 M
Total Revenue (FY 2022)
$52,862 M
Net Income (FY 2025)
$10,833 M
Net Income (FY 2024)
$10,129 M
Net Income (FY 2023)
$8,374 M
Net Income (FY 2022)
$7,514 M
Diluted EPS (FY 2025)
$15.38
Diluted EPS (FY 2024)
$14.01
Diluted EPS (FY 2023)
$11.21
Diluted EPS (FY 2022)
$9.85
Net Interest Income (FY 2025)
$17,364 M
Net Interest Income (FY 2024)
$15,543 M
Net Interest Income (FY 2023)
$13,134 M
Net Interest Income (FY 2022)
$9,895 M
Total Assets (Q2 2026)
$308,203 M
Net Loans (Q2 2026)
$225,055 M
Cash & Equivalents (Q2 2026)
$45,166 M
Total Debt (Q2 2026)
$59,049 M
Stockholders' Equity (Q2 2026)
$34,280 M
Free Cash Flow (FY 2025)
$16,003 M
Free Cash Flow (FY 2024)
$12,139 M
Free Cash Flow (FY 2023)
$16,996 M
Free Cash Flow (FY 2022)
$19,224 M
CapEx (FY 2025)
$2,425 M
Dividends Paid (FY 2025)
$2,271 M
Buybacks (FY 2025)
$5,814 M
Shares Outstanding (FY 2025)
686 M
Shares Outstanding (FY 2024)
702 M
Shares Outstanding (FY 2023)
723 M
Revenue (Q2 2026)
$19,637 M
Net Income (Q2 2026)
$3,110 M
Diluted EPS (Q2 2026)
$4.53
Strengths
Concerns
American Express delivered record Q2 2026 results with revenue of $19.6B (+10.0% YoY) and EPS of $4.53 (+11.0% YoY), extending its streak of 8 consecutive quarters above $3.50 EPS. The company maintains elite profitability metrics (34.38% ROE, 16.14% net margin, 20.32% operating margin) with strong FCF of $16B in 2025 and $8.09B returned to shareholders through dividends and buybacks. The fortress balance sheet ($308.2B in assets, $45.2B cash, $34.3B equity) supports the premium valuation (P/E 18.33, P/B 5.95x), though key risks include consumer credit cycle exposure, NIM sensitivity to Fed rate changes, and elevated CapEx spending.
Macro: Fed delivered first rate hike in 3+ years: unanimous +25 bp to 3.75-4.00% target range under Chair Kevin Warsh, who called inflation \"too high\" and signaled another hike possible this year — clearly hawkish. Polymarket pricing: 96% probability of NO Fed rate cuts in 2026 (up 1.7pp week-over-week), only 8% odds of US recession by year-end 2026 (down 4.0pp), and just 18% odds of inflation exceeding 4.5% in 2026 (down 1pp). Market is firmly in a \"higher for longer, possibly higher still\" regime.